Background: Loss of white adipose tissue (WAT), associated with type 1 diabetes (DM1), contributes to increased chronic systemic inflammation. Aim: The aim of this study was to investigate the effects of leucine supplementation and resistance training (RT) in attenuating WAT loss and improving inflammatory parameters and glucose metabolism in DM1 rats. Methods: Thirty-two male Wistar rats were distributed into four groups: DA (sedentary and supplemented with non-essential amino acids (NEAA)), DL (sedentary and supplemented with leucine), DTA (submitted to RT and supplemented with NEAA) and DTL (submitted to RT and supplemented with leucine). DM1 was induced by streptozotocin (STZ). An 8-week period of RT consisted of climbing a ladder with a progressively increased load, and supplementation was offered in the feed. Results: Glycemia, polyphagia and polydipsia were lower in DL, DTA and DTL groups compared with the DA group by approximately 20% (p<.0001), 28% (p¼.004) and 64% (p<.0001), respectively. Weight of total WAT and retroperitoneal adipose tissue (RPAT) were higher by approximately 21% (p¼.01) and 54% (p¼.0004), respectively, in DL, DTA and DTL groups compared with DA. However, gene expression of adiponectin and leptin in RPAT was only increased by RT (DTA and DTL) compared with DA and DL by approximately 93% (p<.0001) and 78% (p¼.0002), respectively. Similarly, the levels of adiponectin in the serum, tissue IL-10 (RPAT) and serum IL-10 were only increased in DTA and DTL compared with DA and DL by approximately 31% (p¼.03), 45% (p¼.0009) and 35% (p¼.003), respectively. Conclusions: Both interventions, isolated or together, reduced hyperglycemia and excessive loss of WAT, but RT was the main factor responsible for attenuating inflammation.
Introduction
Diabetes mellitus is one of the main worldwide epidemics of the 21st century (Tabish, 2007) , being divided into two major types (DM1 and DM2), which have certain characteristics in common, including chronic glucose elevation and glycosylated products in the blood (Sheetz and King, 2002) , besides polyuria, polyphagy, polydipsia (American Diabetes Association, 2011) and chronic inflammation (Wellen and Hotamisligil, 2005) . In DM2 there is resistance to insulin and an excess of white adipose tissue (WAT) (Ravussin and Smith, 2006) , unlike DM1, in which there is an absence or deficit of circulating insulin, leading to excess fatigue and weight loss, mainly caused by muscle tissue and WAT loss (Chawla et al., 2013) .
It is well established that WAT loss is associated with an increased chronic inflammatory state (Kosteli et al., 2010) . The WAT catabolism augments the level of non-esterified fatty acids (NEFAs) in the blood, which in turn contributes to a higher content of pro-inflammatory factors, such as tumor necrosis factor alpha (TNF-a), interleukin 6 (IL-6) and interferon gamma (IFN-g) (Catalán et al., 2012) in an autocrine, paracrine and endocrine manner (MohamedAli et al., 1998) . In addition, adiponectin, considered an important anti-inflammatory hormone (Yamamoto et al., 2005) , is synthesized by adipocytes (Scherer et al., 1995) , and less tissue would represent impaired adiponectin secretion. Thus, prevention or attenuation of WAT loss might be effective in preventing inflammation (Nowakowski, 2014) .
In DM2, a number of interventions, such as metformin and lifestyle modifications, have been proved to be effective in treatment (Knowler et al., 2002) . Williams (2008) verified some promising results after endurance and RT, including improved insulin sensitivity, glycemic control, blood pressure and cardiovascular diseases. However, in DM1 the effects of physical activity are less clear. Chimen et al. (2012) and Yardley et al. (2013) mentioned that both types of training could reduce glycemia, providing evidence that this kind of intervention might have certain benefits. Nevertheless, due to the predominant oxidative metabolism (Gollnick, 1985) , endurance training might contribute to additional WAT loss. Thus, RT, which predominantly utilizes glucose as an energy source (Tesch et al., 1986) , would give better results.
Another possible intervention that might improve DM1 by preserving WAT is leucine supplementation. TorresLeal et al. (2011) observed an increase in fat content and adipocyte volume in rats previously exposed to a high-fat diet with leucine in comparison with a high-fat diet without leucine, corroborating Zeanandin et al. (2012) , in which 18-month-old rats presented adipocyte hypertrophy and hyperplasia after 6 months of chronic leucine supplementation. Additionally, leucine supplementation improved adiponectin secretion (Torres-Leal et al., 2011) .
Thus, the hypothesis of this study is that leucine supplementation and RT may attenuate the loss of WAT, thereby avoiding inflammation as well as improving DM1 parameters, such as hyperglycemia and insulin resistance.
Materials and methods

Animals
Thirty-two Wistar male rats were accommodated from birth until they were 12 weeks old in the Animal House of the University of São Paulo. The animals were housed in individual cages in a controlled environment at 23 C and a relative air humidity of 55+10%, under a 12-h light/12-h dark cycle (lights on at 14 h) for a period of 12 weeks.
Animals were randomly divided into four groups (n¼8 per group): DA (sedentary and supplemented with non-essential amino acids (NEAA)), DL (sedentary and supplemented with leucine), DTA (submitted to RT and supplemented with NEAA) and DTL (submitted to RT and supplemented with leucine). A group composed of healthy rats (n¼8) was used just to confirm diabetes by oral glucose tolerance test (OGTT), insulin tolerance test (ITT) and insulin in the serum.
Rats had free access to water and chow. Body weight, food and water intake were monitored two times per week. All animal procedures were approved by the ethics committee on animal experimentation of the University of São Paulo (protocol no. CEUA/FCF/380).
Type 1 diabetes induction
Five-day-old rats were fasted for 8 hours. The diabetic groups were injected with streptozotocin (STZ) (120 mg/kg body weight, intraperitoneally) freshly diluted in citrate buffer (10 mM, Na citrate, pH 4.5). After injection, all rats were kept with their respective mothers until they were 21 days old. In the group with healthy rats only citrate buffer, instead of STZ, was injected. The induction of diabetes by STZ is effective and well established in the literature (Wu and Yan, 2015) .
Diet composition
The experimental diets were prepared according to the recommendations of the American Institute of Nutrition for adult rats (Reeves et al. 1993) . For groups DL and DTL, 50 g of cornstarch was replaced by 50 g of L-leucine (Ajinomoto Interamericana Indústria e Comércio Ltda, São Paulo, Brazil) by the addition of 50 g of leucine to each 950 g of chow, amounting to 5% of L-leucine. For groups DA and DTA, 39.45 g of non-essential amino acids (6.79 g of alanine, 10.15 g of aspartic acid, 5.72 g of glycine, 8.78 g of proline and 8.01 g of serine) replaced 39.45 g of cornstarch to maintain both chows isonitrogenous. Chow was consumed from when rats were 22 days old until 8 hours before euthanasia.
Resistance training (RT)
The RT protocol was performed according to Hornberger and Farrar (2004) , and consisted of climbing a ladder from bottom to top (1.1 Â 0.18 m, 2 cm grid, 80 incline), with the load progressively increased. The adaptation period was performed between the 22nd and 26th days. In this period, each exercise session consisted of five climbs with no load, and with 2 minutes' rest between climbs. From the 29th day until the 80th day, RT took place. The training protocol consisted of nine climbs, with 2 minutes' rest after each climb, and 48 hours' rest between sessions. On day 29, the first climb consisted of 50% of body weight (bw), the second consisted of 75% of bw, the third 90% of bw, and the fourth 100% of bw. For the fifth climb, 30 g was added, and if the animal was able to perform the complete climb, another 30 g was again added. When the animal could no longer climb, the maximum load (ML) was defined. This load was performed until the ninth repetition. The next session started with 50% of the ML established in the previous training session. The second climb consisted of 75% of the ML, the third 90% of ML, and the fourth 100% of ML, and 30 g was added for the fifth climb. This procedure was carried out until the ML was reached, and, when this occurred, this load was carried until the ninth climb. Thus, every session started with 50% of the ML established in the previous training session, and finished with a new ML, which was used to start the next training session.
Oral glucose tolerance test (OGTT)
The tests were performed at 8 a.m. after 8 hours' fasting. In 11-week-old animals, the glucose load (75 mg glucose/ 100 g body weight) was introduced via gavage, and tail blood samples were collected at 0, 5, 15, 30, 60, 90 and 120 minutes after gavage. Glycemia was accessed by a glucometer (One Touch Ultra, Johnson & Johnson).
Insulin tolerance test (ITT)
The determination of the glycemic curve was performed on the fourth day in the 11-week-old animals. After 8 hours of fasting, insulin was injected intraperitoneally (75mU/100 g body weight). Glycemia of caudal capillary was analyzed by glycosometer at 0 (basal), 3, 6, 10, 15, 30, 45 and 60 minutes after the insulin administration.
Euthanasia
At the end of their 12th week, the rats were fasted for 8 hours, and 48 hours after the last exercise session, the animals were anesthetized with rodent cocktail (xylazine hydrochloride (20 mg/mL), ketamine hydrochloride (100 mg/mL), acepromazine (20 mg/mL) and distilled water (4.5/4.5/1.8/7.2, v/v)). Trunk blood samples were collected after decapitation and centrifuged, and serum was stored in a freezer at À80 C. Subcutaneous (SCAT), epididymal (EAT), mesenteric (MEAT) and retroperitoneal (RPAT) white adipose fat pads were totally excised, weighed and stored in a freezer at À80 C for future analysis.
Protein analysis in adipose tissue
Frozen RPAT (0.1-0.3 g) was homogenized in RIPA buffer (0.625% Nonidet P-40, 0.625% sodium deoxycholate, 6.25 mM sodium phosphate and 1 mM ethylenediamine tetraacetic acid at pH 7.4) containing 10 mg/mL of protease inhibitor cocktail (Sigma-Aldrich, St. Louis, Missouri).
Homogenates were centrifuged at 12,000 g for 10 min at 4 C, and the supernatant was saved for measurements of IL-1b, IL-10, IL-6 and TNF-a protein expression by an enzyme-linked immunosorbent assay (ELISA) and read with Luminex 100 (Multiplexed Biomarker Immunoassays for Luminex ® Instrumentation/xMAP ® TechnologyLuminex Corporation, Austin, USA). IL-1b, IL-10 and IL-6 levels were determined with Milliplex ® Map Kits (Millipore Corporation, Billerica, USA) by Multiplex assay.
Hormone and cytokine serum level
Blood samples were centrifuged at 2500 g at 4 C for 15 minutes to obtain serum for determination of TNF-a, IL-1b, IL-10, IL-6, leptin, insulin and adiponectin by ELISA and read with Luminex 100. IL-1b, IL-10, IL-6, leptin, insulin and adiponectin levels were determined with Milliplex ® Map Kits.
Reverse transcription-polymerase chain reaction (RT-PCR)
The total RNA was isolated from RPAT samples with Trizol ® reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations and then homogenized. RNA concentrations were determined by measuring the absorbance in 260/280 nm in Synergy H1 Multi-Mode Reader (Thermo Fisher Scientific Inc., Waltham, MA, USA). Complementary DNA synthesis was carried out using a high capacity cDNA reverse transcription kit (Life Technologies, Grand Island, NY, USA), which consisted of an assay mix containing 1 mg total RNA, 2 mL 10Â RT buffer, 0.8 mL 25Â dNTP mix (100 mM), 2 mL 10Â random primers, 1 mL MultiScribe™ reverse transcriptase and 4.2 mL of nuclease-free water in a final volume of 20 mL. The thermal cycler conditions were: 25 C for 10 min, then 37 C for 120 min followed by 85 C for 5 min. Then, 20 ng of cDNA was mixed with 2Â SYBR Green fast PCR master mix -and primers (Life Technologies, Grand Island, NY, USA) -in a final volume of 20 mL for quantitative PCR (qPCR), performed in the Quantstudio 12 K Real Time Systems (Life Technologies, Grand Island, NY, USA). The mRNA levels were determined by the comparative Ct method. For each sample, a DCt value was obtained by subtracting glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene values from those of the gene of interest. The average DCt value of the control group was then subtracted from the sample to derive a ÀDDCt value. The expression of each gene was evaluated by 2ÀDDCt according to Livak and Schmittgen (2001) .
Statistical analysis
Data are expressed as mean + SEM. Statistical analysis was performed with Student's t-test for insulin in the serum of the DA and healthy groups. Statistical analysis for glycemic values (OGTT and ITT), chow and water consumption, and weekly weight evolution index, was performed by two-way analysis of variance (ANOVA), and for the other parameters one-way ANOVA was used, followed by the Tukey post-hoc test. A significant level of p<.05 was employed for all comparisons. Statistical analysis was carried out with GraphPad Prism software, version 6.0 (GraphPad Software, San Diego, CA, USA).
Results
Food consumption, water intake and weekly weight evolution Water intake was also higher in the DA group (538.9+118.6 mL/week) by approximately 64% in comparison with the DL (228.6+32.58 mL/week), DTA (174.6+21.68 mL/week) and DTL (177.5+17.83 mL/week) groups, especially from the eighth week until the end of the experiment (p<.0001). These results evidenced that both interventions were able to reduce polyphagia and polydipsia.
There was no significant difference between groups on weekly weight evolution.
Body and tissue weight
Total WAT weight was increased in DL (12.62+0.73 g), DTA (12.47+0.70 g) and DTL (12.57+0.49 g) groups by 27, 25 and 26%, respectively, compared with DA (9.93+0.56 g) (p¼.01). RPAT weight was also increased in the DL (3.42+0.28 g), DTA (3.35+0.31 g) and DTL (3.49+0.36 g) groups by 54%, 53% and 55%, respectively, compared with the DA group (1.56+0.22 g) (p¼.0004). Besides, although there was no statistical difference in MEAT (p¼.5970), SCAT (p¼.8499) and EAT (p¼.9909), the three depots were impaired in DA when compared with the other three groups (Table 1) .
Oral glucose tolerance test, insulin tolerance test and insulin in the serum Figure 2 (a) shows glycemia in DA and a group comprising healthy animals during OGTT. In the DA group, glycemia was much higher compared with the healthy animals (DA: (Figure 2(b) ) (p<.0001). In comparison with the insulin levels of DA and healthy animals, it was observed that the diabetic animals had a 67% lower insulin level than the healthy ones (DA: 1411+438.3 pg/mL and healthy group: 4292+418.4 pg/mL), showing a deficiency of insulin, characteristic of type 1 diabetes (Figure 2(c) ) (p¼.001).
In Figure 2 (d), the glycemic level was higher in the DA group (224.8+29.88 mg/dL) in comparison with the DL (165.3+16.53 mg/dL), DTA (197.3+23.66 mg/dL) and DTL (178.9+18.41 mg/dL) groups. Only in the DL group was the glycemia lower than in the DA group throughout the OGTT (p<.0001). Figure 2(e) shows the ITT of all diabetic groups (DA, DL, DTA and DTL). Three minutes after insulin administration, the DL (132.0+8.66 mg/dL), DTA (123.2+2.21 mg/dL) and DTL (124.4+8.98 mg/dL) groups had lower glycemia compared with DA (177.8+20.47 mg/dL), showing that, in some way, leucine supplementation and RT, isolated or together, improved insulin activity (p¼.0008). There was no statistical difference in insulin in the serum between the groups: DA: 1981+476.9 pg/mL; DL: 2407+330.9 pg/mL; DTA: 2542+423.4 pg/mL; DTL: 2194+190.6 pg/mL (p¼.7364) (Figure 2(f) ).
Adipokine gene expression of retroperitoneal adipose tissue
The gene expression of adiponectin and leptin is shown in Table 2 . The concentration of adiponectin mRNA was increased in DTA and DTL compared with the DA and DL groups by approximately 93% (p<.0001). Leptin mRNA was also increased in the trained groups by approximately 78% compared with the untrained ones (p¼.0002). These results show that RT, but not leucine supplementation, increased adiponectin and leptin gene expression.
Cytokines in the retroperitoneal adipose tissue
There was no statistical difference in the content of IL-1b (p¼.1094), IL-6 (p¼.3038) or TNF-a (p¼.8031) between groups. However, the content of IL-10 was significantly increased in the DTA (107%, p <.01 versus DA; 67%, p <.05 versus DL) and DTL groups (103%, p <.01 versus DA; 64%, p <.05 versus DL), proving that RT increased this parameter (p¼.0009) ( Table 3) .
Hormones and cytokines in the serum
There was no statistical difference in the content of leptin (p¼.1246), IL-1b (p¼.1148) or TNF-a (p¼.0970) between groups. The content of adiponectin was increased in DTA (45%, p <.05 versus DA; 43%, p <.05 versus DL) and DTL (46%, p <.05 versus DA; 43%, p <.05 versus DL) (p¼.003). IL-6 was also increased in DTA (58%, p <.05) and DTL (50%, p <.05) compared with DA (p¼.006), and a similar increase in IL-10 concentration was shown in DTA (49%, p <.01 versus DA; 55%, p <.05 versus DL) and DTL (51%, p <.05 versus DA; 57%, p <.05 versus DL) (p¼.003). The increased concentrations of adiponectin, IL-6 and IL-10 in the serum suggest that the RT was the main factor responsible for the improvement in inflammatory status (Table 4) .
Discussion
DM1 affects around 5-10% of the population (Vatandost et al., 2012) and is characterized by an absence or relative deficit of circulating insulin (Sheetz and King, 2002) . A comparison of the DA group and a group made up of healthy rats showed that the diabetes induced in this study was indeed type 1, due to glucose intolerance (Figure 2(a) ), deficiency of insulin concentration in the blood (Figure 2(c) ) and the absence of insulin resistance in group DA (Figure 2(b) ). It is noteworthy that diabetic animals were not treated with insulin, as they had an insulin deficiency rather than an absence of insulin. Apart from insulin, which is the standard treatment for the disease (Nathan, 2014) , various non-pharmacological strategies are capable of improving aspects of diabetes, and leucine supplementation and RT can be seen as promising interventions. In this study, the DA group showed increased glucose intolerance in comparison with the other groups, evidencing that leucine and RT improved this parameter. Unlike the non-essential amino acids added to DA and DTA chow, leucine is a ketogenic amino acid (Hutson et al., 2005) , and the reduction in gluconeogenesis might explain the lower quantity of glucose in the blood of the groups supplemented with leucine (DL and DTL). Also, alanine, aspartic acid, glycine, proline and serine are easily converted into glucose in the liver and kidneys (Brosnan, 2003) . RT uses glucose as an energy substrate, which explains the reduction of glycemia in the trained groups (DTA and DTL). The consumption of chow and water was also increased in DA in comparison with the DL, DTA and DTL groups, showing that leucine supplementation and RT reduced polyphagia and polydipsia. Furthermore, the total content of WAT, such as RPAT, was impaired in DA. Taken together, these results raise the possibility that total body weight would be impaired in DA rats. Nevertheless, there was no difference in this parameter between groups. According to Regnell and Lenmark (2011) and Foster et al. (2011) , this could be due to an accumulation of excessive fat in the liver and kidneys, which in turn contributes to the greater weight of these organs. Lynch et al. (2006) pointed out that leucine can regulate adipocyte hypertrophy, leptin secretion, protein synthesis and morphogenesis, in addition to hyperplasia (Pham et al., 2000) , due to mammalian target of rapamycin (mTOR) pathway activation, in order to preserve adipose tissue. Chakrabarti et al. (2010) mentioned that activation of this pathway inhibited certain lipolytic enzymes, such as adipose triglyceride lipase (ATGL) and hormone sensitive lipase (HSL), and increased triacylglycerol (TAG) storage and de novo lipogenesis. It is possible that RT also preserves adipose tissue even better than endurance training, due to the role of aerobic metabolism in the latter. RT generally uses glucose as the main substrate, and for this reason the fat tissue might not be spent.
Besides having an energy function, WAT secretes hormones, such as leptin and adiponectin. Leptin, besides being considered a pro-inflammatory hormone (Barr et al., 1997) , informs the hypothalamus about the status of energy in the body (Benati and Lancha Jr, 2007) and is responsible for satiety. Thus, due to a higher consumption of food in addition to a lower content of WAT, one could speculate that leptin in the DA group might be diminished in comparison with the other groups. Nevertheless, although the gene expression of leptin was lower in DA compared with DTA and DTL, there was no significant difference in serum leptin between groups. It could be argued that leptin does not fulfill the functions as effectively in DA as in the other three groups because there was an increase in the leptin receptor expression due to leucine supplementation (Mao et al. 2011) and/or in the leptin sensitivity in the hypothalamus due to the physical exercise (Ropelle et al., 2010) .
Adiponectin is another hormone secreted only by WAT, but, unlike leptin, it is known to have an anti-inflammatory effect (Ouchi and Walsh, 2007) , being directly related to cardiovascular protection (Shibata et al., 2005) and inversely related to the content of pro-inflammatory cytokines (Fantuzzi, 2005) . According to Moradi (2015) and TorresLeal et al (2011) , obese patients and rats show increased levels of adiponectin in the serum after carrying out RT or receiving leucine supplements, respectively. In this experiment, although there was no difference in the proinflammatory cytokines TNF-a and IL-1b in the serum, the trained groups (DTA and DTL) showed a higher content of adiponectin, IL-10 and IL-6. It is important to note that IL-6 was only increased in the serum of trained groups, but not in the RPAT. Pedersen (2006) reported that, during exercise, an increase of IL-6 secretion might occur due to skeletal muscle action, and in this particular situation, is considered an anti-inflammatory cytokine.
Finally, Yang et al. (2010) and Slentz et al. (2009) mentioned that leucine and exercise might, in different ways, preserve or even increase beta cell mass and function. Souza et al. (2008) consider that improving inflammatory status by increasing anti-inflammatory factors whilst decreasing pro-inflammatory cytokines is an outstanding strategy to stimulate growth and prevent beta cell apoptosis, thus increasing the content of insulin secreted. In this study, there was no difference in systemic insulin between the groups, possibly due to a lack of reduction in pro-inflammatory cytokines. However, in ITT, the groups supplemented with leucine and submitted to RT responded better to insulin administration when compared with DA. Slentz et al. (2009) and Kim et al. (2014) pointed to low intensity endurance exercise as having greater effects on the beta cell function in comparison with vigorous intensity in DM2 and DM1, respectively. Although to our knowledge no research has yet been carried out on comparing the inflammatory status in DM1 after low or high intensity RT, the possibility that a less intense protocol would induce more benefits must be taken into account. On the other hand, in the present study, the high intensity resistance exercise performed by the animals presented interesting results, such as improvement of DM1 and inflammatory parameters. Thus, possibly, the practice of RT with loads up to 80% of one repetition maximum to humans might be beneficial (Harris et al., 2004) . However, the development of scientific studies is necessary to confirm this hypothesis.
Conclusion
In conclusion, the results obtained in this study confirm leucine supplementation and RT as being two effective interventions in order to attenuate certain DM1 parameters. Leucine alone has a key role mostly in the control of homeostasis by preventing excessive WAT loss, thus preserving an important source of energy. Meanwhile, high intensity RT, besides contributing to the maintenance of WAT independently of any supplementation, has an important role in the activation of RPAT of type 1 diabetic rats, counteracting the systemic inflammation by increasing the production of anti-inflammatory factors.
Authors' contributions H.Q.T.R. was responsible for the experimental procedures, data collection and manuscript writing. A.Y.C. was responsible for assisting with manuscript writing and final manuscript review. V.B.L. and C.E.M. contributed to the experimental procedures and data collection. J.T. was responsible for the study design and manuscript review.
